KLC1

Across TCGA pan-cancer cohorts, KLC1 mass-spec protein differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of KLC1’s most consistent transcriptional readouts.

The strongest signal is observed in lung squamous cell carcinoma (LSCC), where KLC1 mass-spec protein is repressed in tumor relative to normal tissue. In most cancer types KLC1 is over-expressed in tumor, although a few such as LSCC show the opposite, repressed pattern.

LSCC, CCRCC, and PDAC are the cancer types where KLC1 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in KLC1 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
LSCC	Female	All	−0.274	<.001	8	view →
CCRCC	Male	All	+0.242	<.001	7	view →
PDAC	All	All	+0.369	.001	6	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

KLC1–LSCC

Open the LSCC breakdown →